glucose
Small moleculeapproved
Inverted sugar syrup is a syrup mixture of the monosaccharides glucose and fructose, made by splitting disaccharide sucrose. This mixture's optical rotation is opposite to that of the original sugar, which is why it is called an invert sugar. Splitting is completed through hydrolytic saccharification. — Wikipedia
Clinical trial activity
385 trials · 355 clinical orgs · 1 marketing orgs
Phase 1
44
Phase 2
52
Phase 3
24
Phase 4
37
Earliest trial started Feb 25, 1998 (NCT00001651)
Timeline
Indications
Approved for
Studied for
- Aging · Phase 4
- Alzheimer Disease · Phase 3
- Amyotrophic Lateral Sclerosis · Phase 2
- Analgesia · Phase 3
- Anemia · Phase 1
- Arthroplasty, Replacement, Knee · Early Phase 1
- Atrial Fibrillation · Phase 4
- Atrial Flutter · Phase 4
- Blood Circulation · Phase 1
- Blood Coagulation Disorders · Phase 4
- Body Weight · Phase 2
- Brain Injuries, Traumatic · Phase 1/Phase 2
- Burns · Phase 4
- Carbohydrates · Early Phase 1
- Cardiac Surgical Procedures · Phase 3
- Cardiovascular Diseases · Phase 4
- Cesarean Section · Phase 1/Phase 2
- Chronic Disease · Phase 1
- Cognition Disorders · Phase 2
- Colorectal Surgery · Phase 3
- Common Cold · Phase 2
- Conjunctivitis, Allergic · Phase 4
- COVID-19 · Phase 3
- Critical Care · Phase 4
- Critical Illness · Phase 3
- Dehydration · Phase 4
- Diabetes Mellitus · Phase 4
- Diabetes Mellitus, Type 1 · Phase 2
- Diabetes Mellitus, Type 2 · Phase 4
- Diet Therapy · Phase 4
- Drug-Related Side Effects and Adverse Reactions · Phase 2
- Drugs, Investigational · Phase 4
- Drug Therapy · Phase 4
- Echocardiography, Transesophageal · Phase 2/Phase 3
- Emergencies · Phase 4
- Epilepsy · Phase 4
- Fatty Liver · Phase 1
- Feeding and Eating Disorders · Phase 4
- General Surgery · Phase 4
- Genetic Diseases, Inborn · Phase 1/Phase 2
- Geriatrics · Early Phase 1
- Glomerulonephritis, IGA · Phase 3
- Glucose Intolerance · Phase 4
- Glucose Metabolism Disorders · Phase 4
- Glycogen Storage Disease Type I · Phase 1/Phase 2
- Healthy Volunteers · Phase 4
- Hearing Loss · Phase 2
- Heart Diseases · Phase 4
- Heart Failure · Phase 4
- Heart Valve Prosthesis Implantation · Phase 3
- Hemodialysis, Home · Phase 4
- Hemorrhage · Phase 4
- Hernia, Inguinal · Phase 4
- HIV Infections · Phase 2/Phase 3
- Hydrocephalus · Phase 3
- Hyperglycemia · Phase 4
- Hyperinsulinism · Phase 1
- Hyperkalemia · Phase 2
- Hyperlipidemias · Phase 4
- Hypernatremia · Phase 4
- Hypertension · Phase 4
- Hypertension, Pulmonary · Phase 2/Phase 3
- Hypoglycemia · Phase 4
- Hypokalemia · Phase 4
- Hyponatremia · Phase 4
- Infant, Newborn · Phase 3
- Infant, Newborn, Diseases · Phase 1/Phase 2
- Infant, Premature · Phase 2
- Infant, Premature, Diseases · Phase 3
- Inflammation · Phase 1
- Insulin · Phase 2
- Insulin Resistance · Phase 4
- Insulin Secretion · Phase 4
- Irritable Bowel Syndrome · Phase 2
- Kidney Failure, Chronic · Phase 4
- Leukemia, Lymphocytic, Chronic, B-Cell · Early Phase 1
- Lung Diseases · Phase 4
- Magnetic Resonance Imaging · Early Phase 1
- Malnutrition · Phase 4
- Metabolic Diseases · Phase 4
- Metabolic Syndrome · Phase 1
- Multiple Sclerosis · Phase 3
- Myocardial Infarction · Phase 4
- Neonatal Screening · Phase 3
- Neonatology · Phase 3
- Non-alcoholic Fatty Liver Disease · Phase 1
- Obesity · Phase 2
- Only Child · Phase 1
- Overweight · Phase 2
- Pain · Phase 4
- Peritoneal Dialysis · Phase 2
- Pneumonia · Phase 1
- Polycystic Ovary Syndrome · Phase 3
- Postoperative Complications · Phase 3
- Postoperative Nausea and Vomiting · Phase 4
- Postoperative Pain · Phase 4
- Postpartum Hemorrhage · Phase 2
- Prediabetic State · Phase 2
- Pregnancy in Diabetics · Phase 2
- Premature Birth · Phase 4
- Problem Behavior · Phase 4
- Pulmonary Arterial Hypertension · Phase 2/Phase 3
- Rectal Diseases · Phase 3
- Regional Blood Flow · Phase 2
- Renal Insufficiency · Phase 4
- Respiratory Distress Syndrome · Phase 2/Phase 3
- Retina · Phase 2
- Sarcopenia · Phase 4
- Schizophrenia · Phase 2
- Sepsis · Phase 4
- Shock, Septic · Phase 3
- Sprains and Strains · Phase 2
- Stomach Diseases · Phase 4
- Stroke · Phase 4
- Tamsulosin · Phase 3
- Telangiectasis · Phase 4
- Tonsillectomy · Phase 4
- Triglycerides · Phase 1
- Urinary Retention · Phase 3
- Vaginosis, Bacterial · Phase 2
- Vagus Nerve · Phase 1
- Varicose Veins · Phase 4
- Vasopressins · Phase 3
- Ventricular Dysfunction, Right · Phase 2/Phase 3
- Wounds and Injuries · Phase 4
Mechanism of action
- Unspecified targetSupplementation
supplementation
Approval history
- approved—
Chemistry & pharmacology
Loading structure…
SMILES
OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O- Mol. weight
- 180.16 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Discontinued
Oral
No
Parenteral
Yes
Topical
No
Sources
- WikipediaInverted sugar syrup ↗
- NCATSED959S6ACY ↗
- ChEMBLCHEMBL1614854 ↗
- ChEMBLCHEMBL1222250 ↗
- ChEMBLCHEMBL1201647 ↗
- WikipediaGlucose ↗
Also known as
- 1,3-beta-glucan
- anhydrous glucose
- anhydrous glucose
- anhydrous glucose
- beta-1,3-glucan
- beta-1,3-glucan
- beta-1,3-glucan
- glucose
- glucose
- glucose
- glucose
- glucose
- glucose
- glucose
- glucose-40
- glucose-40
- glucose anhydrous
- glucose, anhydrous
- glucose, anhydrous
- glucose, liquid
- insta-glucose
- invertose
- invert sugar
- invert sugar
- invert sugar
- invert sugar
- invert sugar
- sugar, invert
- sugar, invert
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06955130 | N/A | Jul 1, 2026 | Rutgers University |
| NCT07311330 | Phase 2 | Jan 31, 2026 | Beijing Inno Medicine Co., Ltd. |
| NCT06930976 | N/A | Oct 1, 2025 | Vanderbilt University |
| NCT07008456 | Phase 2 | Sep 12, 2025 | Aphaia Pharma US LLC |
| NCT07131904 | N/A | Aug 12, 2025 | Bern University of Applied Sciences |
| NCT07013916 | N/A | Jun 30, 2025 | University of London, University of Surrey |
| NCT06799715 | N/A | Feb 6, 2025 | St. Claraspital Basel, University of Basel |
| NCT06714552 | N/A | Dec 31, 2024 | University of Aberdeen, Yakult Honsha Co., LTD |
| NCT06643351 | N/A | Dec 31, 2024 | University of Pittsburgh |
| NCT06558422 | Phase 1 | Dec 1, 2024 | Columbia University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of California, Berkeley |
| NCT06671756 | N/A | Nov 7, 2024 | Baylor University |
| NCT06609356 | Early Phase 1 (Phase 1) | Nov 1, 2024 | Vanderbilt University |
| NCT06638190 | N/A | Oct 21, 2024 | Centro de Edafología y Biología Aplicada del Segura, Universidad Católica San Antonio de Murcia |
| NCT06329544 | N/A | Oct 8, 2024 | Icahn School of Medicine at Mount Sinai, Metabolic Solutions Inc., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| NCT06624956 | Phase 4 | Oct 1, 2024 | University of Washington |
| NCT06424106 | N/A | Oct 1, 2024 | Mayo Clinic |
| NCT06597201 | Phase 4 | Sep 9, 2024 | Government of China |
| NCT06469970 | Phase 4 | Sep 1, 2024 | University of Lorraine |
| NCT06710743 | N/A | Jul 1, 2024 | PepsiCo |
| NCT06325644 | N/A | Jun 1, 2024 | Ohio State University |
Showing 20 of 385 trials
Page 1 / 20
Organizations
Research & Development (355)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Agricultural University of Athens | Academic/Hospital | 15 | 15 | 1 | 2014 |
| University of Toronto | Academic/Hospital | 13 | 13 | 3 | 2010 |
| University of Bern | Academic/Hospital | 11 | 10 | 2 | 2006 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 8 | 1 | 2 | 2006 |
| University of Copenhagen | Academic/Hospital | 8 | 6 | 3 | 2009 |
| University of Vienna | Academic/Hospital | 7 | 5 | 4 | 1999 |
| Vanderbilt University | Academic/Hospital | 7 | 7 | 3 | 2002 |
| Maastricht University | Academic/Hospital | 6 | 4 | 1 | 2009 |
| National University of Singapore | Academic/Hospital | 6 | 6 | 1 | 2016 |
| Ohio State University | Academic/Hospital | 6 | 6 | 1 | 2015 |
| Aarhus University | Academic/Hospital | 5 | 5 | 2 | 2010 |
| Baylor University | Academic/Hospital | 5 | 2 | 2 | 1999 |
| Harvard University | Academic/Hospital | 5 | 2 | 3 | 2006 |
| Merck | For profit | 5 | 4 | 1 | 2007 |
| University of Lyon | Academic/Hospital | 5 | 4 | 2 | 2009 |
| University of Sao Paulo | Academic/Hospital | 5 | 4 | 3 | 2006 |
| Aphaia Pharma US LLC | For profit | 4 | 4 | 2 | 2019 |
| Canadian Institutes of Health Research (CIHR) | Academic/Hospital | 4 | 0 | 1 | 2010 |
| Columbia University | Academic/Hospital | 4 | 4 | 1 | 2023 |
| Rutgers University | Academic/Hospital | 4 | 4 | 1 | 2016 |
355 organizations
Page 1 / 18
Marketing (1)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Baxter | For profit | NDA | Jun 1, 1970 |